In clear cell RCC, SNHG12, as a competitive endogenous RNA, competes with miR-30a-5p to bind to downstream oncogenes RUNX2, IGF-1R and WNT2 to promote tumor cell invasiveness [19]. Here, RUNX2 is linked to neoplasm.